Novel Gene Therapy Strategies
Luigi Naldini
Email: naldini.luigi@hsr.it
Location: DIBIT1 A3, Floor 2, Room 57
Director, San Raffaele Telethon Institute for Gene Therapy
Group Leader, Novel Gene Therapy Strategies Unit
Group Leader, Targeted cancer gene therapy Unit
Full Professor, Vita-Salute San Raffaele University
Luigi Naldini, M.D., Ph.D., is Professor of Cell and Tissue Biology and of Gene and Cell Therapy at the San Raffaele University School of Medicine and Scientific Director of the San Raffaele Telethon Institute for Gene Therapy (Milan, Italy). He has received his medical degree from the University of Turin (Italy) and his PhD from the University “La Sapienza” of Rome (Italy). For the past 25 years he has pioneered the development and the applications of lentiviral vectors for gene therapy, which have become one of the most widely used tools in biomedical research and, upon recently entering clinical testing, are providing a long-sought hope of cures for several currently untreatable and otherwise deadly human diseases. Throughout this time, he has continued to investigate new strategies to overcome the major hurdles to safe and effective gene transfer, bringing about innovative solutions that are not only being translated into new therapeutic strategies for genetic disease and cancer, but have also allowed novel insights into hematopoietic stem cell function, induction of immunological tolerance, and tumor angiogenesis. His work also contributed to advance the use of artificial nucleases for targeted genome editing in cell and gene therapy. He has published over 280 scientific papers. SCOPUS Author h-index: 101. He is also co-founder of three innovative biotech start-up companies: Genenta (recently listed on Nasdaq), Epsilen Bio (now acquired by Chroma Medicine) and Genespire.
Naldini has a long and consolidated experience in mentoring young scientists, many of whom now hold positions in prestigious research center and academic institutions. A complete list of researchers who trained under Luigi Naldini can be found here.
Luca Libelli, Assistant to Prof. Luigi Naldini
E-mail: libelli.luca@hsr.it
Emanuela Vicentini, Administrative Support to SR-Tiget Research & Development, Events and Communication Coordinator
E-mail: vicentini.emanuela@hsr.it
2008-present: Director, San Raffaele Telethon Institute for Gene Therapy, Milan, Italy
2003-2008: Co-director, San Raffaele Telethon Institute for Gene Therapy, Milan, Italy
Since 2002:Full Professor of Cell and Tissue Biology, Vita-Salute San Raffaele University, Milan, Italy
1998-2002; Associate Professor, Turin Univ. Med. School and Director, Laboratory for Gene Transfer and Therapy, Institute for Cancer Research and Treatment, Candiolo (Turin), Italy
1996-1998: Director, Lentiviral Vector Project, Cell Genesys, Foster City, CA, USA
1994-1996:Visiting Scientist, Inder Verma Lab, Salk Institute for Biological Studies, La Jolla, CA, USA
1990-1996: Assistant Professor, University of Turin, Italy
2019 Founder, Fondazione Piemontese per la Ricerca sul Cancro, Turin, Italy
Since 2016 Member of the Italian National Advisory Committee on Biosafety, Biotechnology and Life Sciences
Since 2016 Advisory Editorial Board Member, EMBO Molecular Medicine and Cell Stem Cell
2015-2017 Member of the Human Gene Editing Study Committee by the National Academies of Sciences, Engineering and Medicine of the USA
2012-2017 Member of the Scientific Committee, Institute for Cancer Research, Turin, Italy Member of the Scientific Advisor/Board: Bayer, Biomarine, Cellgene, Chroma, Editas EMA, Epsilen Bio, FDA, Genenta Sciences, Genespire, Genethon, Lund University, Magenta, Maxcyte, Novartis, Sangamo Sciences, Sanofi, Tessera, WHO Since 2015 Member of the Advisory Committee to the Italian Ministry of Health
2012-2016 Member of the Board of Directors, Human Genetics Foundation, Turin, Italy
2012-2014 Member of the Board of Directors (2008-12) and President (2012-14) of the European Society of Gene and Cell Therapy (ESGCT)
2005-2012 Member of the Board of Directors (2005-2008) and of the Advisory Council (2008-2012) of the American Society of Gene and Cell Therapy (ASGCT)
2006-present Member of the Strategic Committee and Board of Directors, San Raffaele Scientific Institute, Milan, Italy
Since 2002 Member of the Scientific Committees of American Association of Cancer Research (AACR), ASGCT, ESGCT, International Society for Stem Cell Research (ISSCR), International Society of Cell Therapy (ISCT)
2019 Nominated “Grande Ufficiale” dell’Ordine “Al Merito della Repubblica Italiana”, one of the highest ranking honor in Italy, from the President of the Republic and the Prime Minister of Italy, on December 27th
2019 The Global Health Pioneer Award, Dubai, AE
2019 The Louis-Jeantet Prize for Medicine, Lausanne, CH 2017 The Beutler Prize from the American Society of Hematology (ASH), USA
2016 Premio Capitani, Milan, Italy
2015 Outstanding Achievement Award from the European Society of Gene and Cell Therapy in The Jimenez Diaz Prize, Conchita Rábago de Jiménez Díaz Foundation, Madrid, Spain
2015 Honorary doctorate from the Vrije University, Brussel, Belgium
2014 Premio Gili Agostinelli for Biological and Medical Sciences from the Accademia delle Scienze di Torino, Turin, Italy
2014 Outstanding Achievement Award from the American Society of Gene and Cell Therapy Human Gene Therapy “Pioneer Award”
2012 Awarded the Premio Sapio of the Italian Research (Health Area) Research abstracts submitted from Luigi Naldini’s laboratory to the ASGCT and/or ESGCT Annual Meetings were selected among the top abstracts at the 1999, 2000, 2001, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011 and 2012 annual conferences.
2009 Awarded the European Research Council (ERC) Advanced Investigator Grant, which recognizes top EU scientists with an outstanding achievement track record
2008 Elected Member of EMBO, the European Molecular Biology Organization
Research performed in Prof. Luigi Naldini’s laboratory led to the filing of 21 family-originating patents.
1987-1990 Post-doctoral fellow, Yossi Schlessinger Lab, USA
1987-1983 PhD in Cell and Tissue Biology with P.M. Comoglio, Turin University, Italy
1983 MD, Turin University, Italy